by Riley Nolan | Mar 17, 2022 | Events, Featured
As a woman-led and women-owned company in biotech, EpiVax is a statistical outlier in the male dominated world of STEM. In an effort to address some of the gender disparities in our industry, Dr. Annie De Groot and EpiVax’s Katie Porter launched the...
by Riley Nolan | Nov 4, 2021 | Events, Featured
Updated: Thank you to those that joined us for the seminar! It was a successful meeting with many wonderful talks. Please find photos from the event below. Are you interested in a recording of the seminar? Please submit a request below. Please note, some talks were...
by Annie De Groot | Oct 8, 2021 | Events
From October 25th to the 28th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Scientific Director of Protein Therapeutics and Aimee Mattei, Immunoinformatics Program Manager, Peptide Therapeutics. Aimee and Brian will...
by Annie De Groot | Oct 8, 2021 | Events, Featured
EpiVax had a large contingent at AAPS PharmSci360 in Philadelphia! Check out the EpiVax itinerary below! Always nice to connect with our partners, clients, and friends in Philly. Annie De Groot, MD Speaker Spotlight: Engineering Better Biologics: Does Nature Know...
by Riley Nolan | Sep 10, 2021 | Events, Featured
EpiVax participated in the 2021 International Society for Vaccines (ISV) Annual Virtual Congress September 13-15, 2021. The 2021 Congress was a busy one, it’s been a difficult but innovative period for the vaccine development community. Multiple EpiVax...
by Riley Nolan | May 21, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot and Director of Analysis Frances Terry co-presented “Engineering Better Biologics: Does Nature Know Best?” at the 2021 AAPS NBC conference May 19th 2021. Outline: Background on T cells / Immunogenicity EpiMatrix, JanusMatrix ...
